Effect of immunotherapy on seasonal changes in serum-specific IgE and IgG4 in patients with pollen allergic rhinitis

Laryngoscope

Volumn 107, Issue 9, 1997, Pages 1270-1275

  Ohashi, Yoshihiro ^a   Tanaka, Ayaki ^a   Kakinoki, Yasushi ^a   Ohno, Yoshiharu ^a   Sakamoto, Hirokazu ^a   Kato, Akifumi ^a   Masamoto, Tateo ^a   Washio, Yushi ^a   Nakai, Yoshiaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ADULT; ALLERGIC RHINITIS; ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; MALE; POLLEN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALLERGENS; ANTIGENS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; JAPAN; MALE; MIDDLE AGED; POLLEN; REMISSION INDUCTION; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TIME FACTORS; TREATMENT OUTCOME; TREES;

EID: 0030868647     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199709000-00021     Document Type: Article

References (22)

1. Pence HL. Immunotherapy for mountain cedar pollinosis: a double-blind controlled study. J Allergy Clin Immunol 1976;58:39-49.
2. Lichtenstein LM. A single year of immunotherapy for ragweed hay fever: immunologic and clinical studies. Ann Intern Med 1971;663:75-83.
3. Mosmann TR, Coffman RH. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111-47.
4. Ohashi Y, Nakai Y, Okamoto H, et al. Serum level of interleukin-4 in patients with perennial allergic rhinitis during allergen-specific immunotherapy. Scand J Immunol 43;1996:680-6.
5. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
6. + T cells from allergic individuals. J Exp Med 1993;178:2123-9.
7. Ohashi Y, Nakai Y, Sakamoto H, et al. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy. Ann Allergy Asthma Immunol 1996;77:203-8.
8. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972;109:129-35.
9. Ohashi Y, Nakai Y, Kihara S, et al. House dust mite-specific IgE, IgG1, and IgG4 antibodies in patients with perennial rhinitis. Ann Otol Rhinol Laryngol 1987;96:434-7.
10. Ohashi Y, Nakai Y, Okamoto H, et al. Significant correlation between symptomatic score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol (in press).
11. Parish WE. Short-term anaphylactic IgG antibodies in human sera. Lancet 1970;2:591-2.
12. Gwynn CM, Ingram J, Almosawai T, et al. Bronchial provocation tests in atopic patients with allergen specific IgG4 antibodies. Lancet 1982;1:254-6.
13. Djurup R, Mailing HJ: High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin Allergy 1987;17:459-68.
14. Stenworth DR, Smith AK. Inhibition of reagin-mediated PCA reactions in baboons by the human IgG4 sub-class. Clin Allergy 1973;3:37-41.
15. Nakagawa T, Kozeki H, Katagiri J, et al. Changes of house-dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial allergic rhinitis. Int Arch Allergy Appl Immunol 1987;82:95-9.
16. Urbanek R, Kemeny DM, Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin Allergy 1986;16:317-22.
17. Ohashi Y, Nakai Y, Ohno Y, et al. Natural course of serum specific IgE and IgG4 for a span of eight years in untreated patients with perennial allergic rhinitis. Laryngoscope 1997, (in press).
18. Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. J Allergy Clin Immunol 1990;86:292-305.
19. Ohashi Y, Nakai Y, Kakinoki Y, et al. Effect of immunotherapy on serum level of eosinophil cationic protein in seasonal allergic rhinitis. Clin Otolaryngol (in press).
20. Prete GD, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140: 4193-8.
21. Kato S, Nakai Y, Ohashi Y, Kato M. RAST in diagnosis and therapy of allergic rhinitis. Acta Otolaryngol (Stockh) 1991; Suppl 486:209-16.
22. Ohashi Y, Nakai Y, Ikeoka H, et al. Increased ciliary beating frequency of nasal mucosa following immunotherapy for allergy. Ann Otol Rhinol Laryngol 1989;98:350-4.